Timothée Olivier

13PUBLICATIONS
25CO-AUTHORS
Molecular targetsTumour immunologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Comparative language studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 06, 2026
Efficacy of Immune Checkpoint Inhibitors and Oncoviruses in Solid Tumors.

Hiba Mechahougui, Léna Royston, Catia Vieira Gomes

|Jul 17, 2025
Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management.

Maxime Borgeaud, Timothée Olivier, Jair Bar

|Jan 23, 2025
[Oncology. Antibody-drug conjugates : a challenging innovation].

Rita S Brito, Timothée Olivier, Anita Wolfer

|Sep 28, 2024
Imatinib remains the best frontline therapy in patients with chronic myeloid leukemia: Critical analysis of the ASC4FIRST trial.

Nethra Srinivasan, Timothée Olivier, Alyson Haslam

|Jun 27, 2024
A novel framework to assess haematology and oncology registration trials: The THEOREMM project.

Timothée Olivier, Alyson Haslam, Patricia Burke

|May 17, 2024
[Interpreting a randomized trial in oncology: Key points for the clinician].

Timothée Olivier

Pageof 3